Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Accounts Payables (2016 - 2025)

INVO Fertility (IVF) has disclosed Accounts Payables for 15 consecutive years, with $2.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Accounts Payables fell 9.94% to $2.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.4 million, a 9.94% decrease, with the full-year FY2024 number at $3.1 million, up 33.61% from a year prior.
  • Accounts Payables was $2.4 million for Q3 2025 at INVO Fertility, up from $2.2 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $4.8 million in Q1 2025 to a low of $306252.0 in Q2 2021.
  • A 5-year average of $1.7 million and a median of $1.8 million in 2023 define the central range for Accounts Payables.
  • Peak YoY movement for Accounts Payables: surged 299.65% in 2023, then fell 9.94% in 2025.
  • INVO Fertility's Accounts Payables stood at $443422.0 in 2021, then surged by 204.23% to $1.3 million in 2022, then soared by 72.74% to $2.3 million in 2023, then skyrocketed by 33.61% to $3.1 million in 2024, then fell by 23.2% to $2.4 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's Accounts Payables are $2.4 million (Q3 2025), $2.2 million (Q2 2025), and $4.8 million (Q1 2025).